Medical
Bristol-Myers Squibb to exit diabetes joint venture - Citi analyst
An announcement made last Thursday of a realignment in priority drug research projects prompted Citi analyst to advise shareholders of a possible interest divestment in diabetes drug joint venture between Bristol-Myers Squibb and AstraZeneca.
Belgian company Arseus buys software company in Brazil
Belgian medical equipment company Arseus struck a deal to acquire a pharmaceutical software maker in Brazil called Alternate Technologies.
Salix Pharma agrees to acquire Santarus for USD2.6 billion
Salix Pharmaceuticals Ltd announced a definitive agreement to buy Santarus Inc for USD2.6 billion. Salix Pharmaceuticals Ltd agreed to purchase Santarus Inc for USD32 per share or USD2.
Top deals of the day - M&As
The following bids, mergers, acquisitions and disposals were reported on Thursday. The following bids, mergers, acquisitions and disposals were reported on Thursday.